Professional Documents
Culture Documents
Joshua Ikwuagwu
Professor Nolen
ENGL 1301
November 4 2021
Analysis of
qualified researchers at the University of Minnesota wrote a peer reviewed study titled
“Depression, Anxiety and Severity of Obesity in Adolescents: Is Emotional Eating the Link?” In
it they study the behavior of adolescents who are overweight and facing mental troubles, such as
depression and anxiety. While the researchers are following the rules of the scientific method,
they made a potentially large mistake in their research, which in could invalidate this entire
study.
The purpose of this research study was to “characterize the impact of depression and
anxiety on the severity of obesity among youth seeking weight management treatment and to
determine the extent to which emotional eating mediates the relationship between depression
and/or anxiety and degree of obesity” (Pg.1). They found this through clinical trials conducted on
obese teenagers between the ages of 12-18 during January 2012 through October 2013.
Of the researchers involved in this study, 1 is the head of the Pediatrics Department at
The University of Minnesota. 4 of them work in the Pediatrics Department of the university, and
the 1 that isn’t belongs to the Division of Biostatistics. The Pediatrics Department has a direct
link to this study since it involves children, and each of the researchers themselves have their
Neuroscience, with a focus on pediatrics. Aaron Kelly and Claudia Fox are the Co-Directors for
Ikwuagwu 2
Minnesota Universities’ Center for Pediatric Obesity Medicine (CPOM). Amy Gross is the
Associate Director for Clinical Care in the Center for Pediatric Obesity Medicine at the
University of Minnesota, and is a member of the Association for Behavior Analysis and The
their expertise in both mental, physical health, and statistical analysis. This adds an extra layer of
On the first page of the article there is a disclaimer at the bottom of the page, stating “Dr.
Kelly serves as a consultant for Takeda Pharmaceuticals and Novo Nordisk Pharmaceuticals and
is the signatory author for a pediatric obesity clinical trial sponsored by Novo Nordisk
Pharmaceuticals; he does not accept personal or professional income for his services. Dr. Kelly
also receives research support from Astra Zeneca Pharmaceuticals in the form of drug/placebo.
Dr. Fox is a site principal investigator for a pediatric obesity clinical trial sponsored by Novo
Nordisk Pharmaceuticals. None of the other authors have disclosures” (Pg.1). Takeda
in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue. In 2014,
just 1 year after this study was published, they released a drug called Contrave. One of the
ingredients for that drug is bupropion, which is known as an anti-depressant. This study is about
proving the link between depression, anxiety, and obesity, and one of its 5 PhD’s also happened
to be working for Takeda during his time researching the study. It could be possible that his
purpose in assisting this study was to perform the research for Takeda and sell them the
information before it was published. After all the study concluded in 2013, but this research was
published 3 years later. Their acknowledgement of this possible conflict of interest shows they
Ikwuagwu 3
are not worried about how people view their motivations behind the study. This gives a comfort
On page 3 of the study, under the measures section, there is mentions to how they came
to receive the data. “Depression was assessed with the Patient Health Questionnaire (PHQ-9), a
9-item, self-report survey on a 4-point Likert scale (0=’not at all’ to 3=’nearly every day’).
Anxiety was assessed with the Generalized Anxiety Disorder Scale (GAD-7), a 7-item self-
report survey on a 4-point Likert scale (0=’not at all’ to 3=’nearly every day’). A PHQ-9 score
cut point of ≥11 was considered positive for detecting depression15 and a GAD-7 score cut point
of ≥ 10 was considered positive for detecting anxiety. […] Emotional eating was measured by
patient self-report on the Child Eating Behavior Questionnaire (CEBQ), Emotional Over-Eating
subscale.18 The CEBQ was originally designed as a parent report of child eating behavior, yet
precedent has been made for using a modified version of the CEBQ as an adolescent self-report
measure.19 As such, prefix statements were modified from ‘My child…’ to ‘I…’ The four items
comprising the Emotional Over-Eating subscale are: ‘eat more when anxious,’ ‘eat more when
annoyed,’ ‘eat more when worried,’ and ‘eat more when nothing else to do.’ Each item was rated
on a 5-point Likert scale (1=never to 5=always). The mean of the four items was used as the
emotional eating score”. Seeing as this is a self-report, a question can be brought up to the
researchers. How can they trust their reports? It is no secret that teenagers lie to cover their
tracks, but this study ranged from 12-18, with a mean of 15. A study conducted by the Victoria
W. Dykstra, Teena Willoughby, Angela D. Evans for The Journal of Adolescence, titled “Lying
to friends: Examining lie-telling, friendship quality, and depressive symptoms over time during
late childhood and adolescence”, lie telling in proportionate with having poor mental health,
Ikwuagwu 4
which we know the majority of their experiment base has. Even with the researcher’s credibility,
how can users of their research trust children to speak the truths of their situation.
pediatrics and mental wellness. They well all professors at The University of Minnesota, both co-
directors of the Center for Pediatric Obesity Medicine were on this team. There was even a large
chance that this research was used in the production of antidepressant-based diet pill. Yet, the
downfall of this study was their reliance on the words of children to be the bridge between reality
and their hypothesis. It is possible the children told the truth, but other researchers cannot rely on
the possibility of the truth. A peer reviewed study is supposed to be thoroughly done in order to
guarantee its data can be trusted, and with that being said, this study cannot be trusted.
Ikwuagwu 5
Citations
Emotional Eating the Link?” Clinical Pediatrics, U.S. National Library of Medicine, Oct. 2016,
“Takeda and Orexigen Announce FDA Approval of Contrave® (Naltrexone HCI and
Bupropion HCI) Extended-Release Tablets for Chronic Weight Management.” Takeda and
Orexigen Announce FDA Approval of Contrave® (Naltrexone HCI and Bupropion HCI)
https://www.takeda.com/newsroom/newsreleases/2014/takeda-and-orexigen-announce-fda-
approval-of-contrave-naltrexone-hci-and-bupropion-hci-extended-release-tablets-for-chronic-
weight-management/.
Lying to friends: Examining lie-telling, friendship quality, and depressive symptoms over
Journal of Adolescence 84:123
Academic Press 2020-10-01
01401971
Ikwuagwu 6
10.1016/j.adolescence.2020.08.003